|Last Price$74.08||Day Change (%)0.42%|
|Open Price$73.88||Day Change ($)0.31|
|Day Range73.42–74.45||52-Week Range53.33–75.66|
As of Wed 12/24/2014 02:09 PM EST | USD
Ladies and gentlemen, thank you for standing by, and welcome to the Medtronic Fourth Quarter Earnings Conference Call. All lines have been placed on mute to prevent any background noise. After the speakers' remarks, there will be a question-and-answer session. Thank you.
Inspire Medical Systems to present at 33rd annual J.P. Morgan Healthcare Conference
United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin
Covidien Files 8K - Other Events
Announcement under Irish Takeover Rules Relevant Securities in Issue – December 23, 2014
The device maker's planned acquisition of Covidien will make it a force to be reckoned with.
Research and Markets: Global Electrophysiology Devices Market 2014-2018 With Boston Scientific, GE Healthcare, Medtronic , Philips Healthcare & St. Jude Medical Dominating
The firm is on track to meet our full-year estimates, and our $60 per share fair value estimate and wide moat rating are intact.
Medtronic's $17 Billion Bond Sale Is Year's Largest -- Update
Medtronic Selling Bonds for Covidien Acquisition -- Update